Information on the Target
InfraRed Capital Partners has successfully completed the sale of its investment in Celsus Holding Pty Ltd, which operates the Royal Adelaide Hospital (RAH) Public-Private Partnership (PPP). The RAH is considered South Australia’s flagship healthcare institution, notable for being one of the most technologically advanced hospitals in Australia. Since its operational commencement in 2017, it has been integral in providing a comprehensive range of medical services to a vast number of patients; serving approximately 85,000 inpatients and 400,000 outpatients each year across its 800-bed facility.
This state-of-the-art hospital, built under a 35-year PPP agreement with the South Australian Government, is managed by SA Health. InfraRed played an essential role in the development and construction phases of the RAH, applying its extensive experience in healthcare and infrastructure management. They also facilitated connections between the RAH and other UK healthcare facilities within their portfolio to share best practices and established Environmental, Social, and Governance (ESG) measures from the project's inception.
Industry Overview in South Australia
The healthcare sector in South Australia is characterized by a robust infrastructure and a commitment to high-quality clinical services. As one of the primary health service providers, the RAH underscores the State's commitment to modern healthcare delivery. The establishment of advanced facilities such as the RAH aligns with the rising demand for healthcare services driven by population growth and aging demographics in the region. The integration of innovative technologies and methodologies continues to evolve, underscoring South Australia’s reputation for excellence in medical care.
Additionally, the investment in healthcare infrastructure comes in response to the increasing complexity of medical needs. Facilities are increasingly expected not only to deliver routine care but also to accommodate high-acuity and specialized services. Initiatives that promote sustainability, such as green building certifications, are becoming essential, marking South Australia’s hospitals among the leaders in sustainable healthcare practices in the country.
With the increasing emphasis on quality of care, the South Australian healthcare environment is transitioning towards integrated care models that emphasize preventive care and chronic disease management. This trend is complemented by significant public and private investments, aimed at enhancing service delivery methodologies and patient outcomes.
In summary, the healthcare sector in South Australia is dynamic and poised for continued advancement. The investment in high-capacity facilities and the integration of cutting-edge technologies supports a vision of sustainable and comprehensive healthcare, setting a benchmark for future developments.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
The Rationale Behind the Deal
InfraRed’s investment in the RAH was predicated on establishing a premier health service facility that would not only meet the immediate healthcare needs of South Australians but also serve as a model for sustainable healthcare practices. Throughout the investment period, InfraRed focused on embedding ESG principles, which have since formed the operational backbone of the hospital’s functionality.
The sale marks a strategic exit, allowing InfraRed to realize returns from its stewardship while opening the door to new investment prospects within the region. InfraRed has articulated a commitment to continue seeking attractive opportunities, particularly in sectors such as healthcare, where they can leverage their extensive knowledge and experience.
Information About the Investor
InfraRed Capital Partners is a prominent international infrastructure investment manager with over 190 professionals operating from multiple offices, including London, New York, Sydney, and Seoul. With a solid track record spanning 25 years, InfraRed has established itself as a vital player in the infrastructure investment space, managing over US$14 billion in equity capital across various funds focused on income and capital growth strategies.
InfraRed's operational ethos is heavily grounded in sustainability, striving to create lasting positive impacts through all its investments. The firm has maintained a long-standing commitment to responsible investment principles, evidenced by its status as a signatory to the Principles of Responsible Investment since 2011. Additionally, InfraRed has consistently achieved top ratings for its infrastructure business, underscoring its commitment to ESG considerations in its investment strategies.
View of Dealert
In evaluating InfraRed's investment and subsequent divestment from the Royal Adelaide Hospital, this deal can be regarded as a prudent investment choice marked by strategic foresight. The hospital, being a cornerstone of South Australia’s healthcare infrastructure, reflects the successful execution of a project that aligned with community needs while also satisfying growing demands for sustainable practices. The incorporation of ESG criteria into the RAH's operational framework not only enhanced its appeal as an investment but also ensured long-term viability and societal benefit.
Furthermore, the exit strategy appears well-timed, capitalizing on the heightened value created during the investment period. InfraRed’s approach to leveraging best practices from their wider portfolio demonstrates a proactive management style conducive to optimizing operational efficiency and patient care at the RAH. Such strategic integrations are indicative of strong governance, which is a critical factor in assessing the viability of similar investments.
Looking towards the future, InfraRed's indication that they will continue pursuing attractive investment opportunities in the region bodes well for both stakeholders and the communities they serve. Their foundation in sustainable and responsible investing positions them to effectively tap into emerging market opportunities within South Australia’s evolving healthcare landscape.
Ultimately, InfraRed's undertaking in the RAH exemplifies a model investment in public-private partnerships—balancing financial return with social responsibility, reflecting a holistic approach to infrastructural development that could serve as a benchmark for future initiatives.
Similar Deals
Flerie Invest AB → Nanologica AB (publ)
2025
CVC Capital Partners → CompuGroup Medical
2025
Advantage Partners (AP) and LYFE Capital Investment Management Ltd. → Nihon Chouzai Co., Ltd.
2025
Cadwell Industries, Inc. → Seer Medical
2025
GHO Capital Partners LLP and Ampersand Capital Partners → Avid Bioservices, Inc.
2024
InfraRed Capital Partners
invested in
Celsus Holding Pty Ltd
in 2023
in a Public-to-Private (P2P) deal